FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40 | -65.2% | 19,031 | -21.5% | 0.00% | -100.0% |
| Q2 2023 | $115 | -79.2% | 24,251 | -75.1% | 0.00% | -80.0% |
| Q1 2023 | $554 | -77.7% | 97,235 | -60.4% | 0.01% | -86.1% |
| Q4 2022 | $2,480 | -99.6% | 245,758 | +864.7% | 0.04% | +414.3% |
| Q3 2022 | $571,000 | -29.6% | 25,474 | +86.1% | 0.01% | -36.4% |
| Q3 2021 | $811,000 | -6.8% | 13,686 | +36.6% | 0.01% | +10.0% |
| Q2 2021 | $870,000 | -29.9% | 10,020 | -26.6% | 0.01% | -16.7% |
| Q4 2020 | $1,241,000 | +364.8% | 13,651 | +13.6% | 0.01% | -20.0% |
| Q1 2020 | $267,000 | – | 12,014 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |